YUSNAIDA HERNANDEZ IZNAGA: Open Payments
NPI 1720663255 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,283 in 80 payments from 21 companies in 2025. Trend: 2023 $1,434 · 2024 $2,136 · 2025 $3,283
Food & beverage: $3,188Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $1,157 |
| Galderma Laboratories, L.P. | 12 | $250 |
| Journey Medical Corporation | 2 | $235 |
| Arcutis Biotherapeutics, Inc. | 3 | $181 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $180 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $176 |
| GENZYME CORPORATION | 3 | $172 |
| ABBVIE INC. | 3 | $156 |
| E.R. Squibb & Sons, L.L.C. | 6 | $150 |
| Janssen Scientific Affairs, LLC | 1 | $137 |
Products named: TREMFYA, NEMLUVIO, Zoryve, Winlevi, SPEVIGO, DUPIXENT, SKYRIZI, Sotyktu.
Industry payments across FL — which companies pay providers there.
